MSI2 and ductal breast carcinoma in situ: Notably, MSI2 is located at 17q23.2-23.3 (55.1–55.9 Mb)24; part of an amplicon (17q22-24.2) whose gain is a predictor of invasion in DCIS and of nodal metastasis in invasive duct carcinoma (IDC)31.